PDUFAconf 0.94

Plozasiran — PDUFA

$ARWR · Arrowhead Pharmaceuticals, Inc. · Familial Chylomicronemia Syndrome

Event date

June 24, 2026

in 18 days

Sponsor runway

16 mo

$400.0M liquid

Evidence

“FDA accepted our New Drug Application for plozasiran with a PDUFA target action date of 2026-06-24.”

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

No insider Form 4 activity reported on $ARWR in the 90 days around this event.